Injection of lipopolysaccharide (LPS) into mice was followed by a rapid elevation of colony-stimulating factor (CSF) in the serum. A second, challenging injection of LPS given 3 to 4 days later failed to induce elevated levels of CSF in the serum. Such mice tolerant to LPS were used as an experimental tool to identify the CSF-producing cells which respond to LPS. We observed that generation of LPS-induced CSF in mice tolerant to LPS could be restored by an intraperitoneal injection of spleen cells 24 h before the challenging injection of LPS. Depletion of the adherent cells from the spleen cells reduced the ability of the splenic lymphocytes to restore the capacity of the mice tolerant to LPS to generate serum CSF. Reconstitution of the splenic lymphocytes with 5% thioglycolate-elicited peritoneal macrophages, however, reestablished the restorative capacity of these cells, whereas almost no restoration was observed after direct injection of elicited peritoneal macrophages. These data suggest that the spleen cells are active in generating CSF, provided that macrophages are present and can interact with the splenic lymphocytes to generate LPS-induced CSF in the serum.
Injection of bacterial lipopolysaccharides (LPS) or lipid A, the active part of the LPS molecule, into mice is followed by a variety of pathophysiological changes, one of which is a rapid increase in the serum levels of colonystimulating factor (CSF) (1, 4, 9, 14) . Repeated injections of these bacterial products depresses LPS-induced changes, a phenomenon that was designated as tolerance to LPS. The elevation of serum levels of CSF is also depressed in such mice tolerant to LPS (10, 13, 20) .
CSF can be extracted from a variety of murine tissues, including spleens from normal and LPStreated mice (17, 19) . In view of these studies, an attractive hypothesis is that the spleen is a major source of LPS-induced CSF in the serum. In the present study, we used mice tolerant to LPS as an experimental tool to investigate the possible role of spleen cells in generating LPS-induced serum CSF. We have recently shown that interaction between macrophages and lymphocytes is required to generate CSF in spleen cultures (3) . We now demonstrate that cooperation between macrophages and splenic lymphocytes is required in vivo as well to restore the capacity of mice tolerant to LPS to generate LPS-induced CSF in the serum. (12) . Bone marrow cells (BM) (105/plate) were cloned in soft agar medium on a harder agar base (0.5%) supplemented with 10o of the various dilutions of serum to be tested for CSF activi- mouse. At intervals of 1 to 7 days, the mice were challenged with a second i.v. injection of LPS (25 ,g per mouse). Six hours later, the mice were bled, and their sera were assayed for CSF activity. 24, 48, 72 , and 96 h after the initial injection of LPS. The mice were challenged with a second i.v. injection of LPS 4 days after the initial injection of LPS and bled 6 h later. When spleen cells were injected 3 days after the initial injection of LPS and 1 day before the second challenging injection, the CSF response to LPS was restored (Fig. 2 ). An injection of 5 x 107 spleen cells was the optimal dose for restoring the response to LPS (data not shown). The colonies grown in soft agar cultures supplemented with post-LPS serum from the mice tolerant to LPS which had received spleen cells were similar to those obtained in soft agar cultures supplemented with post-LPS serum from untreated mice. In all of the CSF assays, granulocyte, macrophage, and mixed granulocyte/ macrophage colonies were found in equal proportions per plate. In a second group of experiments, we tested the ability of spleen cells obtained from ICR mice tolerant to LPS to restore the capacity of other mice tolerant to LPS to generate CSF.
Spleen cells (5 x 107) were injected i.p. into ICR mice 3 days after the initial injection of LPS. The challenging injection of LPS was given 24 h after the injection of the spleen cells, and 6 h later the mice were bled and CSF activity in the sera was determined (Table 1) . It can be seen that mice tolerant to LPS, injected with spleen cells obtained from untreated mice 24 h before the challenging injection of LPS, generated high levels of CSF in the serum. Mice tolerant to LPS, injected with spleen cells obtained from other mice tolerant to LPS, generated low levels of CSF (34 colonies per 105 BM cells).
Dependence on macrophages of the restoration of CSF generation. As compared to unfractionated splenic populations, spleen cells depleted of adherent cells were able to restore less than half of the LPS-induced serum CSF response in mice tolerant to LPS (80 colonies per 105 BM cells as compared to 170 colonies per 105 BM cells) ( Table 2) .
In another group of experiments, nonadherent (Table 2) .
To further study the relationship between macrophages and nonadherent cells in the resto- Previous studies have shown that at least two types of tolerance to LPS may occur: an early nonspecific tolerance, which is not associated with humoral factors, and a specific late form of tolerance, which is dependent on transferable humoral factors specific for the endotoxin employed (8) . The present study deals with the early tolerance, which reaches its peak 3 to 4 days after the first injection of LPS. Such early tolerance also occurs when lipid A, the active part of the LPS molecule, is injected into mice (20) . It has been shown that this early tolerance to LPS-and lipid A-induced CSF is not due to the presence of antibodies to LPS or lipid A (13, 20) . It was also shown that the decrease in CSF levels in the serum of the mice tolerant to LPS is not due to the presence of factors inhibitory to CSF (10, 13, 20) . These data suggest, therefore, that in early tolerance to LPS, there may be some defect in the cells which generate the LPSinduced CSF in the serum.
In the present study, we used the early tolerance to LPS as a system in which generation of LPS-induced CSF is depressed. By injecting different cells into such mice tolerant to LPS and measuring their capacity to restore the LPSinduced CSF production, we were able to identify cells that participate in the generation of circulating CSF.
Our data show that injection of spleen cells into mice tolerant to LPS before a challenging administration of LPS efficiently restores the capacity of these mice to generate LPS-induced CSF in the serum. Depletion of the splenic adherent cells reduced the ability of the nonadherent splenic cells to restore this capacity. Passage of spleen cells through Pyrex wool columns depletes adherent cells and leaves a nonadherent cell population of almost pure splenic lymphocytes (7, 16) . In the present study, sequential passage of spleen cells through two Pyrex wool columns resulted in a suspension of nonadherent cells composed of 99% lymphocytes, as assayed by cytology. Thus, the nonadherent cells can be considered to be primarily splenic lymphocytes. Although almost no restoration was observed after direct injection of thioglycolate-elicited peritoneal macrophages, reconstitution of the splenic lymphocytes with 5% peritoneal macrophages reestablished the restorative capacity of the spleen cells. These data suggest that the spleen is an important source of LPS-induced CSF in the serum and that both macrophages and lymphocytes are needed in this process. Macrophages responsive to LPS are crucial to effective restoration of the CSF generation capacity. Peritoneal macrophages from untreated mice mixed with splenic lymphocytes from mice tolerant to LPS were able to mediate restoration of CSF generation, whereas peritoneal macrophages from mice tol- The partial restoration of CSF generation by injection of nonadherent splenic cells into mice tolerant to LPS (Table 2 ) may be due to residual macrophages present in the nonadherent spleen cell suspension (3) . Such a low number of macrophages may be sufficient to interact with the nonadherent spleen cells to show a partial restorative capacity. It was also observed that, although a mixture of peritoneal macrophages from untreated mice and nonadherent splenic cells from mice tolerant to LPS had some capacity to restore the response, injection of macrophages alone did not have such a capacity. In this case, it is possible that the ratio between the injected macrophages and the host splenic cells was not optimal, and consequently low amounts of CSF were generated. Another explanation is that close contact is required between the macrophages and lymphocytes which naturally occurs in the spleen or when a mixture of splenic lymphocytes and macrophages is injected. Such close contact with splenic lymphocytes probably did not occur when macrophages alone were injected i.p. into the mice.
Our present data suggest that spleen cells are a major source of circulating CSF, but the possibility that other organs such as lungs (18) or cells such as resident peritoneal macrophages (2, 5, 6, 15) , which respond directly to LPS in generating CSF in cultures, can also contribute to the circulating serum CSF is not excluded. It should also be noted that, although the present data appear to represent CSF generation by the injected spleen cells, it could also be an indirect effect of the injected cells on another cell population.
In the present study, we demonstrate the importance of macrophages in regulating the generation of LPS-induced serum CSF in mice tolerant to LPS. These data are in line with our previous studies in which we showed that generation of LPS-induced CSF in spleen cultures requires cooperation between macrophages and lymphocytes (2) and that the macrophages are the cells which interact directly with LPS (3). The similarities between our in vivo results in mice tolerant to LPS and our in vitro results in spleen cultures suggests that cooperation between macrophages and lymphocytes is a basic requirement in generation of circulating LPSinduced CSF. In this respect, generation of LPSinduced CSF joins other systems in which macrophage-lymphocyte interactions take place in response to LPS (for a review, see reference 11).
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